ADAMA Past Earnings Performance
Past criteria checks 0/6
ADAMAhan disminuido a un ritmo medio anual de -47.5%, mientras que en la industria Chemicals los ingresos han sido de growing a 12.1% anuales. Los ingresos han sido growing a una tasa media anual de 7.6%.
Key information
-49.0%
Earnings growth rate
-48.4%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 7.0% |
| Return on equity | -7.3% |
| Net Margin | -4.9% |
| Next Earnings Update | 26 Apr 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How ADAMA makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 32,779 | -1,606 | 5,348 | 483 |
| 30 Sep 23 | 33,964 | -1,201 | 5,547 | 534 |
| 30 Jun 23 | 35,839 | -365 | 5,642 | 565 |
| 31 Mar 23 | 36,977 | 265 | 5,826 | 583 |
| 31 Dec 22 | 37,382 | 609 | 5,882 | 578 |
| 30 Sep 22 | 36,628 | 929 | 4,687 | 576 |
| 30 Jun 22 | 34,771 | 522 | 4,914 | 549 |
| 31 Mar 22 | 32,867 | 436 | 4,998 | 521 |
| 31 Dec 21 | 31,039 | 157 | 5,122 | 501 |
| 30 Sep 21 | 30,044 | 124 | 6,312 | 539 |
| 30 Jun 21 | 29,388 | 515 | 6,090 | 518 |
| 31 Mar 21 | 28,850 | 518 | 5,968 | 497 |
| 31 Dec 20 | 28,445 | 353 | 6,033 | 479 |
| 30 Sep 20 | 28,171 | -293 | 6,142 | 399 |
| 30 Jun 20 | 28,068 | -107 | 6,161 | 414 |
| 31 Mar 20 | 27,558 | -106 | 6,244 | 432 |
| 31 Dec 19 | 27,563 | 277 | 6,271 | 436 |
| 30 Sep 19 | 27,222 | 633 | 6,204 | 497 |
| 30 Jun 19 | 26,844 | 647 | 6,108 | 497 |
| 31 Mar 19 | 26,898 | 782 | 5,996 | 459 |
| 31 Dec 18 | 26,867 | 2,448 | 5,769 | 442 |
| 30 Sep 18 | 25,353 | 2,556 | 5,718 | 426 |
| 30 Jun 18 | 24,689 | 2,618 | 5,479 | 517 |
| 31 Mar 18 | 25,288 | 2,862 | 5,735 | 381 |
| 31 Dec 17 | 23,820 | 1,546 | 5,406 | 360 |
| 30 Sep 17 | 23,359 | 1,302 | 5,324 | 197 |
| 30 Jun 17 | 23,067 | 1,118 | 5,478 | 0 |
| 31 Mar 17 | 22,003 | 438 | 5,243 | 12 |
| 31 Dec 16 | 22,070 | 369 | 5,217 | 0 |
| 30 Sep 16 | 21,440 | 515 | 4,785 | 50 |
| 30 Jun 16 | 20,720 | 388 | 4,508 | 99 |
| 31 Mar 16 | 19,688 | 829 | 4,125 | 194 |
| 31 Dec 15 | 19,892 | 715 | 4,146 | 196 |
| 30 Sep 15 | 19,631 | 615 | 4,136 | 192 |
| 30 Jun 15 | 19,554 | 777 | 4,150 | 193 |
| 31 Mar 15 | 19,704 | 827 | 4,170 | 194 |
| 31 Dec 14 | 19,978 | 908 | 4,242 | 208 |
| 30 Sep 14 | 19,661 | 941 | 4,193 | 214 |
| 30 Jun 14 | 19,734 | 915 | 4,173 | 215 |
| 31 Mar 14 | 19,276 | 844 | 4,076 | 217 |
| 31 Dec 13 | 18,624 | 770 | 3,863 | 204 |
| 30 Sep 13 | 18,365 | 823 | 3,778 | 199 |
| 30 Jun 13 | 17,884 | 796 | 3,696 | 192 |
Beneficios de calidad: 000553 actualmente no es rentable.
Creciente margen de beneficios: 000553 actualmente no es rentable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Tendencia de beneficios: 000553 no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 47.5% al año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de 000553 en el último año con su media de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: 000553 no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el del sector Chemicals (-27.7%).
Return on Equity
Alto ROE: 000553 tiene un Rendimiento de los fondos propios negativo (-5.31%), ya que actualmente no es rentable.